Yes, thrombosis of six segmental pulmonary arteries can absolutely cause pulmonary hypertension.
Chronic thrombotic obstruction at the segmental level is a well-recognized cause of chronic thromboembolic pulmonary hypertension (CTEPH), classified as Group 6 pulmonary hypertension according to the ESC/ERS guidelines 1, 2.
Pathophysiologic Mechanism
The development of pulmonary hypertension from segmental artery thrombosis follows this pathway:
- Initial thrombotic obstruction: When thrombi fail to resolve after acute pulmonary embolism, they become incorporated into the vessel wall at the main, lobar, segmental, or subsegmental levels 2, 3
- Vascular remodeling: Over time, the embolic material transforms into fibrous and elastic tissue, creating bands, webs, and chronic obstruction 3
- Secondary small-vessel vasculopathy: Critically, chronic obstruction triggers a pulmonary microvascular arteriopathy in non-obstructed vessels, resembling idiopathic pulmonary arterial hypertension 3
- Hemodynamic consequence: Pulmonary hypertension develops when the remaining vascular bed cannot accommodate cardiac output, either from the degree of proximal obstruction alone or combined with secondary small-vessel disease 3
Clinical Classification and Diagnostic Criteria
CTEPH is definitively diagnosed when pre-capillary pulmonary hypertension (mean PAP ≥25 mmHg, PCWP ≤15 mmHg, PVR >3 Wood units) occurs with multiple chronic/organized occlusive thrombi/emboli in the elastic pulmonary arteries, including segmental and subsegmental vessels 2.
The surgical classification system specifically recognizes segmental disease:
- Type 3 disease (30% of CTEPH cases): Fibrosis, intimal webbing, and thickening within distal segmental and subsegmental arteries only 3
- This represents the most challenging surgical scenario but confirms that segmental-level disease alone can cause clinically significant pulmonary hypertension
Critical Clinical Considerations
Extent of Obstruction Matters
Six segmental arteries represent substantial vascular territory. The pulmonary arterial tree has approximately 10 segmental arteries per lung (20 total), so obstruction of 6 segments represents roughly 30% of the segmental circulation—sufficient to cause hemodynamic compromise, particularly when combined with secondary microvascular remodeling 3.
The "Mismatch" Phenomenon
There is often poor correlation between the degree of angiographic obstruction and pulmonary arterial pressure elevation 3. This occurs because:
- Secondary small-vessel arteriopathy contributes significantly to elevated pulmonary vascular resistance
- Total PVR in CTEPH patients exceeds that of acute PE patients with similar proximal obstruction
- Pulmonary hypertension can progress even without recurrent thromboembolism 3
Diagnostic Pitfall
Do not assume segmental-level disease is "too distal" to cause pulmonary hypertension. The guidelines explicitly include segmental and subsegmental vessels in the CTEPH definition 2, and the surgical classification confirms that isolated segmental disease (Type 3) causes pulmonary hypertension requiring treatment 3.
Management Implications
All patients with unexplained pulmonary hypertension should be evaluated for CTEPH, regardless of whether thrombi are at the main, lobar, or segmental level 2:
- Ventilation/perfusion scanning is the screening test of choice
- Multi-row CT angiography follows if V/Q shows perfusion defects
- Referral to an expert CTEPH center is mandatory once imaging suggests chronic thromboembolic disease 2
- Right heart catheterization and pulmonary angiography confirm diagnosis and guide treatment
- Lifelong anticoagulation is indicated 2
Treatment options depend on location and extent:
- Pulmonary endarterectomy remains first-line for accessible disease
- Balloon pulmonary angioplasty for segmental/subsegmental disease 4, 5
- Pulmonary hypertension-specific medical therapy for inoperable patients or residual PH 2, 5
The bottom line: Six segmental artery thromboses represent sufficient vascular obstruction to cause CTEPH, particularly when combined with the inevitable secondary microvascular remodeling that accompanies chronic thromboembolic obstruction.